Jump to content

Abortion industry

Edit links
From Wikipedia, the free encyclopedia

A demonstration against abortion in front of a Planned Parenthood's building

The abortion industry refers to the organizations, providers, distribution channels and economic arrangements involved in delivering abortion services, including clinic-based care, referral agencies, and direct-to-patient medication abortion via telehealth and online pharmacies.[1][2] The term is also a rhetorical device in partisan discourse, often used pejoratively in political communication and advocacy to describe abortion providers and allied organisations.[3][4][5]

Terminology and usage

[edit]

Scholarly and public health literature typically uses descriptive terms such as abortion providers, abortion services or reproductive health services when analysing organisation, financing and delivery of care.[1] By contrast, the phrase abortion industry is common in political commentary and advocacy (especially among anti-abortion groups) to characterise providers and networks in critical terms.[3][6][7]

Historical development

[edit]

Historians describe varied forms of abortion provision across the 19th and early 20th centuries, followed by the mid-to-late 20th-century growth of clinic-based services and organised referral networks in jurisdictions where abortion was legal or liberalised.[2][8] Research on cross-border access documents revealed how referral agencies and travel created markets for services when local provision was restricted.[2]

Providers and organisational structures

[edit]

Abortion services are delivered by a mix of independent clinics, hospital-based services, national nonprofit networks and for-profit providers; in the 21st century, telehealth organisations and online pharmacies have become prominent channels for medication abortion.[9][10] As of March 2024, there were 765 brick-and-mortar clinics providing abortion care in the United States, down from 807 in 2020, with no clinics in 14 states enforcing total bans at that time.[11] Facility databases also track a rapid rise of telehealth providers, enabled in some jurisdictions by "shield laws" protecting clinicians who prescribe across state lines.[12]

Economics and market dynamics

[edit]

Scholars and public health researchers examine costs and funding sources, as well as how regulation shapes supply, demand and market structure for abortion services.[1] In the U.S., medication abortions accounted for about 63% of all abortions in 2023—a marked rise from 2020—reflecting both patient preferences and policy changes affecting access to procedural care.[13][14][15] Studies report that a growing share of abortions occur via telehealth channels; one 2024 analysis estimated ~19% of U.S. abortions were provided through telehealth as of May 2024.[16]

Access, geography and telemedicine

[edit]

Following the U.S. Supreme Court's 2022 Dobbs decision, multiple studies document increases in average travel time to in-person abortion facilities and a rise in telemedicine provision (including shipping pills into states with bans).[17][18] Peer-reviewed work on online provision and self-managed medication abortion—including studies of Women on Web and Aid Access—finds effectiveness and safety under supported telemedicine models in settings with legal or geographic barriers.[19][20][10] Global guidance from the World Health Organization recognises that abortion can be safely managed with recommended methods in appropriate settings, including self-management in early pregnancy under specified conditions.[21]

Regulation and policy impacts

[edit]

Funding rules, facility regulations, telehealth policies and criminal penalties shape where and how services are delivered and affect the mix of clinic-based vs. remote provision.[22] Analyses of facility numbers indicate a net reduction in brick-and-mortar clinics after 2020, concentrated in states with bans, alongside growth in telehealth service availability and use.[11][23]

Controversies and criticism

[edit]

Political and advocacy groups frequently use the term abortion industry in critiques of providers, alleging unsafe conditions or conflicts over public funding.[7][24]

Claims and evidence in public discourse

[edit]
Common claims in public discourse about an "abortion industry" and what high-quality sources report
Claim (reformulated) What reliable sources report Key sources
Aborted fetal tissue is used in consumer products (e.g., food or cosmetics) Independent fact-checks and the U.S. FDA say consumer foods do not contain fetal tissue. Confusion stems from decades-old laboratory cell lines used in research/testing; these are not ingredients in final products. Similar claims about cosmetics are unsubstantiated in mainstream reporting; when cell-line-derived proteins have been referenced in marketing or R&D, they are not fetal tissue in the product itself. "Food products do not contain human fetal cells". Reuters. Reuters. 6 December 2022. Retrieved 13 September 2025.; "No, food products don't contain fetal tissue". AP News. Associated Press. 25 January 2023. Retrieved 13 September 2025.; "PepsiCo drinks do not contain 'aborted fetal cells'". Reuters. Reuters. 15 July 2021. Retrieved 13 September 2025.
"Fetal remains are sold for profit" U.S. federal law prohibits the transfer of human fetal tissue for "valuable consideration;" only reimbursement of reasonable costs (e.g., transportation, processing) is permitted. Violations are criminal offenses. Federal guidance and Congressional research summaries explain these restrictions. "42 U.S.C. § 289g-2 — Prohibitions regarding human fetal tissue". Legal Information Institute. Cornell Law School. Retrieved 13 September 2025.; "Fetal Tissue Research: Frequently Asked Questions". Congressional Research Service. Washington, D.C.: Library of Congress. 10 June 2021. Retrieved 13 September 2025.; "HHS Grants Policy Statement §4.1.14 (Human Fetal Tissue Research)". NIH. U.S. Department of Health & Human Services. Retrieved 13 September 2025.
"Adrenochrome is harvested from children and sold" This is a conspiracy theory narrative. Adrenochrome is a well-known oxidation product of epinephrine that can be synthesized; there is no evidence of harvesting from children. Fact-checks link such claims to QAnon and similar internet myths. "Adrenochrome". Encyclopædia Britannica. Britannica. 22 August 2025. Retrieved 13 September 2025.; "'Adrenochrome' keg is an art project, not a Heineken barrel transported by Shell". Reuters. Reuters. 20 March 2023. Retrieved 13 September 2025.; "Online conspiracies link Pixar's use of "A113" with adrenochrome". Reuters. Reuters. 18 July 2023. Retrieved 13 September 2025.
"Most abortions happen late in pregnancy" CDC surveillance shows the vast majority occur early: in 2022, 92.8% at ≤13 weeks' gestation; only about 1% at ≥21 weeks among reporting areas. "Abortion Surveillance — United States, 2022". MMWR. Atlanta: Centers for Disease Control and Prevention. 2024. Retrieved 13 September 2025.
"Abortion is largely paid by taxpayers; funders have a financial interest in higher volume" Federal Medicaid dollars are restricted by the Hyde Amendment (life endangerment, rape, incest). Some states (≈20) use state-only funds to cover additional abortions; many others do not, leaving patients to self-pay or rely on private insurance or abortion funds. Prices vary by method and delivery: KFF reports 2023 median $600 at brick-and-mortar clinics for medication abortion vs $150 via virtual clinics; state Medicaid reimbursements vary widely. These policies explain who pays and are not evidence of "profit from tissue." Diep, Karen (15 July 2025). "Abortion Trends Before and After Dobbs". KFF. San Francisco. Retrieved 13 September 2025.; "The Hyde Amendment and Coverage for Abortion Services under Medicaid". KFF. 14 March 2024. Retrieved 13 September 2025.; "State Funding of Abortions Under Medicaid". KFF State Health Facts. KFF. 5 November 2024. Retrieved 13 September 2025.; "Medicaid reimbursement ranges for abortion services". KFF. 2024–2025. Retrieved 13 September 2025.
"People of color get most abortions because of targeted practices by providers" CDC data show disparities by race/ethnicity among reporting areas (e.g., 2022: 39.5% Black, 31.9% White, 21.2% Hispanic). CDC cautions that race/ethnicity are markers, not drivers, and differences reflect broader structural and socioeconomic factors and access barriers. "Abortion Surveillance — United States, 2022". MMWR. Atlanta: Centers for Disease Control and Prevention. 2024. Retrieved 13 September 2025.
"Abortion causes breast cancer or infertility" Major medical bodies report no causal link between induced abortion and breast cancer; legal abortion care is safe with rare major complications. "Abortion and Breast Cancer Risk". American Cancer Society. ACS. 7 June 2024. Retrieved 13 September 2025.; National Academies of Sciences, Engineering, and Medicine (2018). "The Safety and Quality of Abortion Care in the United States (Summary)". NCBI Bookshelf. Washington, D.C.: National Academies Press. Retrieved 13 September 2025.{{cite web}}: CS1 maint: multiple names: authors list (link); "Reproductive History and Cancer Risk". NCI. National Cancer Institute. 9 November 2016. Retrieved 13 September 2025.
"Medication abortion is unregulated/unsafe" Mifepristone has been FDA-approved since 2000 with Risk Evaluation and Mitigation Strategy (REMS) controls; FDA's 2024 adverse-event summary and independent reviews find very low rates of serious complications and extremely low mortality. "Mifepristone U.S. Post-Marketing Adverse Events Summary through 12/31/2024". FDA. Silver Spring, MD: U.S. Food and Drug Administration. 31 December 2024. Retrieved 13 September 2025.; National Academies of Sciences, Engineering, and Medicine (2018). "The Safety and Quality of Abortion Care in the United States". National Academies Press. Washington, D.C. Retrieved 13 September 2025.{{cite web}}: CS1 maint: multiple names: authors list (link)

See also

[edit]

References

[edit]
  1. ^ a b c Weitz, Tracy A. (2024). "Making sense of the economics of abortion in the United States". Perspectives on Sexual and Reproductive Health. 56 (3). Wiley/Planned Parenthood Federation of America: 199–210. doi:10.1111/psrh.12288. PMC 11606007. PMID 39537337.
  2. ^ a b c Elvins, Sarah; Parkin, Katherine (2025). "The business of abortion: referral services, cross-border consumption, and Canadian women's access to abortion in New York State, 1970–1972". Enterprise & Society. 26. Cambridge University Press: 197–217. doi:10.1017/eso.2023.61.
  3. ^ a b Newsweek (15 February 2022). "The Abortion Industry, Like Big Tobacco Before It, Undermines Science". Newsweek. Retrieved 13 September 2025.
  4. ^ Silva, Martha; Stolow, Jeni; Burdick, Micki; Mercieca, Amy (2025). "Contested narratives: A qualitative analysis of abortion testimonies in Louisiana legislature". Frontiers in Global Women's Health. 6 1533813. doi:10.3389/fgwh.2025.1533813. PMC 12043522. PMID 40313360.
  5. ^ von der H\u00fclst, Marie (2023). The Abortion Debate in the U.S. Media: A Comparative Content Analysis of Fox News and CNN (PDF) (Master's Thesis). Uppsala University. Retrieved 13 September 2025.{{cite thesis}}: CS1 maint: numeric names: authors list (link)
  6. ^ "Fact Sheet: Deficiencies Affecting U.S. Abortion Data Collection and Application". Charlotte Lozier Institute. Susan B. Anthony Pro-Life America. 24 July 2025. Retrieved 13 September 2025.
  7. ^ a b "\"Unsafe\": 50-State Investigative Report Documents Chronic Abuse and Neglect in Abortion Industry". Americans United for Life. 25 January 2021. Retrieved 13 September 2025.
  8. ^ Mohr, James C. (1979). Abortion in America: The Origins and Evolution of National Policy. New York: Oxford University Press. ISBN 978-0-19-987848-2. Retrieved 13 September 2025.
  9. ^ "Abortion in the United States: Fact Sheet". Guttmacher Institute. 15 April 2025. Retrieved 13 September 2025.
  10. ^ a b Brander, Caroline (1 October 2024). "Online medication abortion direct-to-patient fulfilment patterns before and after Dobbs". JAMA Network Open. 7 (10). American Medical Association: e2434675. doi:10.1001/jamanetworkopen.2024.34675. PMC 11452820. PMID 39365583.
  11. ^ a b Jones, Rachel K. (2024). "The Number of Brick-and-Mortar Abortion Clinics Drops, as Total Bans Eliminate Services in 14 States". Guttmacher Institute. Retrieved 13 September 2025.
  12. ^ Schroeder, Riley (August 2024). "Trends in Abortion Services in the United States, 2017–2023" (PDF). ANSIRH Abortion Facility Database Working Paper. Advancing New Standards in Reproductive Health (UCSF). Retrieved 13 September 2025.
  13. ^ Jones, Rachel K.; Friedrich-Karnik, Ariele (19 March 2024). "Medication Abortion Accounted for 63% of All US Abortions in 2023 - An Increase from 53% in 2020". Guttmacher Policy Analysis. Guttmacher Institute. Retrieved 13 September 2025.
  14. ^ Borter, Gabriella (19 March 2024). "More than 60% of US abortions in 2023 were done by pill, study shows". Reuters. Thomson Reuters. Retrieved 13 September 2025.
  15. ^ Associated Press (19 March 2024). "More than six in 10 US abortions in 2023 were done by medication - study". Associated Press. AP. Retrieved 13 September 2025.
  16. ^ Ereme, Kseniya (1 October 2024). "Online pharmacies and telehealth in medication abortion". JAMA Network Open. 7 (10). American Medical Association: e2435404. doi:10.1001/jamanetworkopen.2024.35404. PMID 39365589.
  17. ^ Rader, Brooke (1 December 2022). "Estimated travel time and spatial access to abortion facilities in the US". JAMA. 328 (20). American Medical Association: 2041–2047. doi:10.1001/jama.2022.20424. PMC 9627517. PMID 36318194.
  18. ^ ANSIRH (1 November 2022). "Data show travel time to abortion facilities increased after Dobbs". ANSIRH. University of California, San Francisco. Retrieved 13 September 2025.
  19. ^ Aiken, Abigail R. A. (17 May 2017). "Self-reported outcomes and adverse events after medical abortion through online telemedicine: population based study". BMJ. 357 j2011. BMJ Publishing Group. doi:10.1136/bmj.j2011. PMC 5431774. PMID 28512085. Retrieved 13 September 2025.
  20. ^ Norman, Wendy V. (2017). "Abortion by telemedicine: an equitable option for Irish women". BMJ: Sexual & Reproductive Health. 357 j2237. BMJ Publishing Group. doi:10.1136/bmj.j2237. PMC 5431773. PMID 28512132.
  21. ^ World Health Organization (21 September 2022). "Abortion care guideline (self-management of medical abortion, 2022 update)". WHO. World Health Organization. Retrieved 13 September 2025.
  22. ^ IWPR (2024). "The Economic and Workforce Impact of Restrictive Abortion Laws". Institute for Women's Policy Research. IWPR. Retrieved 13 September 2025.
  23. ^ Schroeder, Riley (20 June 2023). "Availability of telehealth services for medication abortion, 2020–2022" (PDF). ANSIRH Issue Brief. UCSF. Retrieved 13 September 2025.
  24. ^ "Planned Parenthood, Abortion Drugs Major Drivers of U.S. Abortions". Charlotte Lozier Institute. Susan B. Anthony Pro-Life America. 12 June 2025. Retrieved 13 September 2025.

Further reading

[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Abortion_industry&oldid=1322189225"